News
Company delivers 8% revenue growth, expanded margins, and maintains fiscal year 2025 guidance Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback